GlassScriptPhysician profile
Alyson N Buckley
NPI 1598121816
$1,584.14
in general payments reported to CMS, 2019-2025
15 companies · $185 in 2025
The $185 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $567 · 2022: $169 · 2023: $346 · 2024: $317 · 2025: $185.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $848.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $847.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $727.18 | 2021-2025 | Collagenase Santyl, Oasis, Regranex |
| Polynovo North America LLC | $341.30 | 2022-2025 | Novosorb Btm |
| Integra Lifesciences Corporation | $120.64 | 2021 | |
| Convatec INC. | $89.23 | 2021-2023 | |
| Merck Sharp & Dohme LLC | $63.28 | 2023-2024 | Zerbaxa, Dificid, Recarbrio |
| Baxter Healthcare | $44.11 | 2023-2025 | Recothrom, Tisseel |
| Astrazeneca Pharmaceuticals LP | $34.59 | 2023-2024 | Andexxa |
| Kci USA, INC. | $29.91 | 2023 | Prevena Restor Arthroform, Bair Paws |
| Aroa Biosurgery Incorporated | $26.77 | 2022 | |
| Tela Bio, INC. | $22.71 | 2024 | Ovitex 2s |
| Trevena, INC. | $18.94 | 2022 | |
| Mallinckrodt Hospital Products INC. | $18.90 | 2023 | Inomax |
| Paratek Pharmaceuticals, INC. | $16.92 | 2021 | |
| Medline Industries LP | $16.92 | 2024 | Medline, Medline Industries, INC. |
| Teleflex LLC | $12.74 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alyson Buckley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.